DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% MOUTHWASH

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

CHLORHEXIDINE GLUCONATE

から入手可能:

AMD MEDICOM INC

ATCコード:

A01AB03

INN（国際名）:

CHLORHEXIDINE

投薬量:

0.12%

医薬品形態:

MOUTHWASH

構図:

CHLORHEXIDINE GLUCONATE 0.12%

投与経路:

BUCCAL

パッケージ内のユニット:

500ML/4L

処方タイプ:

Prescription

治療領域:

MISCELLANEOUS ANTI-INFECTIVES

製品概要:

Active ingredient group (AIG) number: 0107629007; AHFS:

認証ステータス:

APPROVED

承認日:

1999-06-29

製品の特徴

DentiCare™ Chlorhexidine Gluconate Oral Rinse 0.12% Product
Monograph
Page 1 of 10
PRODUCT MONOGRAPH
PR
DENTICARE
™ CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12%
CHLORHEXIDINE GLUCONATE
0.12%
ORAL RINSE
ANTIGINGIVITIS ORAL RINSE
AMD Medicom Inc.
2555 Chemin de l’Aviation
Pointe-Claire, Montréal, Québec
Canada, H9P 2Z2
www.medicom.ca
Submission Control No: 223628
Date of Preparation:
March 28, 2019
DentiCare™ Chlorhexidine Gluconate Oral Rinse 0.12% Product
Monograph
Page 2 of 10
PRODUCT MONOGRAPH
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12%
0.12% Chlorhexidine Gluconate
THERAPEUTIC CLASSIFICATION
Antigingivitis Oral Rinse
ACTION AND CLINICAL PHARMACOLOGY
DentiCare Chlorhexidine Gluconate Oral Rinse 0.12% provides
antimicrobial activity during oral
rinsing which is maintained between rinsings. Microbiologic sampling
of plaque has shown a
general reduction of both aerobic and anaerobic bacterial counts
through six months’ clinical use
of 0.12% chlorhexidine gluconate oral rinse. Rinsing with 0.12%
chlorhexidine gluconate oral rinse
inhibits the build-up and maturation of plaque by reducing certain
microbes regarded as gingival
pathogens,
thereby
reducing
gingivitis.
0.12%
chlorhexidine
gluconate
oral
rinse
provides
antimicrobial activity during rinsing and for several hours
thereafter. No significant changes in
bacterial sensitivity, overgrowth of potentially opportunistic
organisms or other adverse changes
in the oral microbial flora were observed following the use of a 0.12%
chlorhexidine gluconate
oral rinse for six months. Three months after discontinued use, the
number of bacteria in plaque
had returned to pretreatment levels and sensitivity of plaque bacteria
to chlorhexidine gluconate
remained unchanged.
Studies conducted with human subjects and animals demonstrate that any
ingested chlorhexidine
gluconate is poorly absorbed in the gastrointestinal tract.
Excretion of chlorhexidine gluconate occurred primarily through the
feces (approximately 90%).
Less than 1% of the chlorhexidine gluconate ing